dry eye
Showing NaN - NaN of 17
Dry Eye Trial in United States (0.25% HL036 Ophthalmic Solution, Placebo)
Completed
- Dry Eye
- 0.25% HL036 Ophthalmic Solution
- Placebo
-
Phoenix, Arizona
- +9 more
Jan 4, 2023
Dry Eye, Meibomian Gland Dysfunction Trial in United States (TearCare System, Restasis)
Active, not recruiting
- Dry Eye
- Meibomian Gland Dysfunction
- TearCare System
- Restasis
-
Scottsdale, Arizona
- +13 more
Sep 12, 2022
Dry Eye Trial in United States (Vehicle, SDP-4 Ophthalmic Solution (1.0%))
Completed
- Dry Eye
- Vehicle
- SDP-4 Ophthalmic Solution (1.0%)
-
Garden Grove, California
- +4 more
Aug 11, 2022
Dry Eye Trial in United States (0.3% YP-P10 Ophthalmic Solution, 1% YP-P10 Ophthalmic Solution, YP-P10 Placebo Ophthalmic
Recruiting
- Dry Eye
- 0.3% YP-P10 Ophthalmic Solution
- +2 more
-
Phoenix, Arizona
- +6 more
Jul 15, 2022
Dry Eye Trial in United States (Brimonidine Tartrate, Placebos)
Completed
- Dry Eye
- Brimonidine Tartrate
- Placebos
-
Newport Beach, California
- +15 more
Jun 29, 2022
Dry Eye Trial in United States (Visant Medical Canalicular Plug, Commercially available canalicular plug)
Completed
- Dry Eye
- Visant Medical Canalicular Plug
- Commercially available canalicular plug
-
Scottsdale, Arizona
- +4 more
Jun 2, 2022
Dry Eye, Dry Eye Syndromes Trial in United States (Vehicle Opthalmic Solution, PL9643 Opthalmic Solution)
Recruiting
- Dry Eye
- Dry Eye Syndromes
- Vehicle Opthalmic Solution
- PL9643 Opthalmic Solution
-
Newport Beach, California
- +9 more
Jan 20, 2022
Keratoconjunctivitis Sicca, Dry Eye Trial in United States (tavilermide ophthalmic solution, Placebo)
Completed
- Keratoconjunctivitis Sicca
- Dry Eye
- tavilermide ophthalmic solution
- Placebo
-
Phoenix, Arizona
- +21 more
Oct 18, 2021
Dry Eye Trial in United States (Omega 3 fatty acid, Placebos)
Unknown status
- Dry Eye
- Omega 3 fatty acid
- Placebos
-
Newport Beach, California
- +13 more
Jan 7, 2021
Dry Eye Trial in Newport Beach (Reproxalap Ophthalmic Solution (0.25%) QID, Vehicle Ophthalmic Solution QID, Reproxalap
Completed
- Dry Eye
- Reproxalap Ophthalmic Solution (0.25%) QID
- +3 more
-
Newport Beach, CaliforniaEye Research Foundation
Dec 2, 2020
Dry Eye Trial in United States (SDP-4 Ophthalmic Solution (0.1%), SDP-4 Ophthalmic Solution (1.0%), SDP-4 Ophthalmic Solution
Completed
- Dry Eye
- SDP-4 Ophthalmic Solution (0.1%)
- +3 more
-
Azusa, California
- +25 more
Aug 26, 2020
Dry Eye Trial in Newport Beach, Lexington (TearCare)
Unknown status
- Dry Eye
- TearCare
-
Newport Beach, California
- +1 more
Aug 15, 2018
Dry Eye Trial in United States (DE-110 ophthalmic suspension high dose, DE-110 ophthalmic suspension low dose, Placebo)
Completed
- Dry Eye
- DE-110 ophthalmic suspension high dose
- +2 more
-
Inglewood, California
- +13 more
May 19, 2014